James Goldberg

James Goldberg has a diverse work experience in biotech consulting, health-tech venture capital, and DNA nanotechnology. James co-founded 101 Therapeutics in 2020 and worked as a TMT Consultant at Activate Consulting from 2020 to 2021. Prior to that, they were involved in pharma/biotech consulting at The Dedham Group from 2019 to 2020. From 2018 to 2019, James worked in health-tech venture capital at Health Catalyst Capital Management LLC. James also gained experience in DNA nanotechnology at New York University in 2017 and in immunology at the University of Pennsylvania School of Medicine in 2016. Additionally, they served as a Sergeant in the Israel Defense Forces from 2013 to 2015.

James Goldberg has a B.A in Biochemistry with a minor in Music from New York University. Prior to their studies at New York University, they completed their High School education at Ramaz School. The specific start and end years for both educational institutions were not provided.